Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review

RATIONALE: Heightened inflammatory bowel disease (IBD) activity during pregnancy is associated with higher rates of preterm birth, miscarriage, and low birth weight. Therefore, its adequate treatment is essential, considering the risk–benefit of medication use. Although previous literature has descr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Aragão, Maria Cecília, Beraldo, Rodrigo Fedatto, Marcondes, Mariana Barros, de Barros, Jaqueline Ribeiro, Herrerias, Giédre Soares Prates, Saad-Hossne, Rogerio, Baima, Júlio Pinheiro, Sassaki, Ligia Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702279/
https://www.ncbi.nlm.nih.gov/pubmed/34941109
http://dx.doi.org/10.1097/MD.0000000000028274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702279/
https://www.ncbi.nlm.nih.gov/pubmed/34941109
http://dx.doi.org/10.1097/MD.0000000000028274

Ejemplares similares